article thumbnail

The Pharmaceutical Revolution: AI Developed Drugs

Pacific Prime

The pharmaceutical industry is witnessing a surge in startups exploring the application of machine learning, attracting substantial investments. This Pacific Prime article dives into the transformative impact of AI in drug discovery, The post The Pharmaceutical Revolution: AI Developed Drugs appeared first on Pacific Prime's Blog.

article thumbnail

HR Challenges in the Pharmaceutical Industries

Vantage Circle

All of which will imply how the pharmaceutical industry is likely to conduct its business in the near future. With the constant layoffs, corporate mergers and acquisitions in the pharmaceutical market, and rise in the compensation standards, many businesses have also adopted an outsourcing business model. Development in Technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacy Benefit Manager Reform: What’s on the Horizon? (December 2023 Update)

McDermott Will & Emery Employee Benefits

Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers. Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government.

article thumbnail

Tough questions to ask your broker when evaluating your PBM

Employee Benefit News

The CEO of True Rx Health Strategists shares how to advocate for better pharmaceutical benefits.

article thumbnail

3 PBM programs and capabilities to consider beyond unit cost

Employee Benefit News

Examine adaptability and foresight to understand the intricacies of an evolving pharmaceutical market.

article thumbnail

KinderCare's on-site child care center helps parents at this pharmaceutical firm thrive

Employee Benefit News

The Apple Blossom Learning Center focuses on early education and sustainability, and is just a short walk from the office.

article thumbnail

Drug Discount Review Boards Proposed by Biden Health Agency

McDermott Will & Emery Employee Benefits

The Biden administration recently proposed revising the process behind an outlet for pharmaceutical companies to resolve price fights for those participating in the 340B drug discount program.